Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Accounts Payables (2023 - 2025)

Cannabis Bioscience International Holdings' Accounts Payables history spans 3 years, with the latest figure at $159116.0 for Q4 2025.

  • For Q4 2025, Accounts Payables fell 4.22% year-over-year to $159116.0; the TTM value through Nov 2025 reached $159116.0, down 4.22%, while the annual FY2025 figure was $100343.0, 39.5% down from the prior year.
  • Accounts Payables for Q4 2025 was $159116.0 at Cannabis Bioscience International Holdings, up from $101297.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $257527.0 in Q1 2024 and bottomed at $100343.0 in Q2 2025.
  • The 3-year median for Accounts Payables is $156791.0 (2025), against an average of $156584.8.
  • The largest annual shift saw Accounts Payables skyrocketed 49.02% in 2024 before it crashed 40.02% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $213521.0 in 2023, then fell by 22.2% to $166119.0 in 2024, then fell by 4.22% to $159116.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Accounts Payables are $159116.0 (Q4 2025), $101297.0 (Q3 2025), and $100343.0 (Q2 2025).